NRC Health Effective Income Tax Rate Reconciliation, Tax Credit, Amount
NRC Health (NRC) reported Effective Income Tax Rate Reconciliation, Tax Credit, Amount of $227.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCredits · last filed 2026-03-05
- NRC Health effective income tax rate reconciliation, tax credit, amount for the quarter ending 2012-12-31 was $84.00K.
- NRC Health effective income tax rate reconciliation, tax credit, amount for the quarter ending 2012-09-30 was $87.00K.
- NRC Health effective income tax rate reconciliation, tax credit, amount for the quarter ending 2012-06-30 was $87.00K.
- NRC Health effective income tax rate reconciliation, tax credit, amount for fiscal 2025 was $227.00K, a 43.39% decline from fiscal 2024.
- NRC Health effective income tax rate reconciliation, tax credit, amount for fiscal 2024 was $401.00K, a 29.53% decline from fiscal 2023.
- NRC Health effective income tax rate reconciliation, tax credit, amount for fiscal 2023 was $569.00K, a 39.46% increase from fiscal 2022.
- NRC Health effective income tax rate reconciliation, tax credit, amount for fiscal 2022 was $408.00K, a 50.00% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 3 month | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 6 month | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 9 month | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month |
|---|---|---|---|---|
| 2025-12-31 | $227.00K 10-K · filed 2026-03-05 | |||
| 2024-12-31 | $401.00K 10-K · filed 2026-03-05 | |||
| 2023-12-31 | $569.00K 10-K · filed 2026-03-05 | |||
| 2022-12-31 | $408.00K 10-K · filed 2025-03-17 | |||
| 2021-12-31 | $272.00K 10-K · filed 2024-02-27 | |||
| 2020-12-31 | $261.00K 10-K · filed 2023-03-03 | |||
| 2019-12-31 | $419.00K 10-K · filed 2022-03-04 | |||
| 2018-12-31 | $150.00K 10-K · filed 2021-03-05 | |||
| 2017-12-31 | $130.00K 10-K · filed 2020-03-06 | |||
| 2016-12-31 | $165.00K 10-K · filed 2019-03-08 | |||
| 2015-12-31 | $150.00K 10-K · filed 2018-03-14 | |||
| 2014-12-31 | $150.00K 10-K · filed 2017-03-03 | |||
| 2013-12-31 | $217.00K 10-K · filed 2016-03-04 | |||
| 2012-12-31 | $84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04 | $171.00K derived: sum of 2 quarters · filed 2015-03-04 | $258.00K derived: sum of 3 quarters · filed 2015-03-04 | $282.00K 10-K · filed 2015-03-04 |
| 2012-09-30 | $87.00K 10-Q · filed 2012-11-07 | $174.00K derived: sum of 2 quarters · filed 2012-11-07 | $198.00K 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $87.00K 10-Q · filed 2012-08-10 | $198.00K 10-Q · filed 2012-08-10 | ||
| 2011-12-31 | $132.00K 10-K · filed 2014-03-04 | |||
| 2010-12-31 | $110.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |